Core Scientific [CORZZ] vs Shift4 Payments [FOUR] Detailed Stock Comparison
Core Scientific
NASDAQ
Loading...
Shift4 Payments
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Core Scientific wins in 4 metrics, Shift4 Payments wins in 9 metrics, with 0 ties. Shift4 Payments appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Core Scientific | Shift4 Payments | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 33.90 | N/A |
| Price-to-Book Ratio | N/A | 9.87 | N/A |
| Debt-to-Equity Ratio | -1.09 | 186.68 | Core Scientific |
| PEG Ratio | N/A | -0.83 | N/A |
| EV/EBITDA | 42.21 | 13.76 | Shift4 Payments |
| Profit Margin (TTM) | 23.71% | 6.11% | Core Scientific |
| Operating Margin (TTM) | -28.13% | 9.16% | Shift4 Payments |
| EBITDA Margin (TTM) | N/A | 9.16% | N/A |
| Return on Equity | 160.33% | 18.28% | Core Scientific |
| Return on Assets (TTM) | -6.74% | 3.61% | Shift4 Payments |
| Free Cash Flow (TTM) | $-52.30M | $310.60M | Shift4 Payments |
| 1-Year Return | 26.88% | 9.39% | Core Scientific |
| Price-to-Sales Ratio (TTM) | 8.23 | 2.21 | Shift4 Payments |
| Enterprise Value | $4.57B | $8.37B | Shift4 Payments |
| EV/Revenue Ratio | 8.95 | 2.32 | Shift4 Payments |
| Gross Profit Margin (TTM) | 6.39% | 30.27% | Shift4 Payments |
| Revenue per Share (TTM) | $1 | $52 | Shift4 Payments |
| Earnings per Share (Diluted) | N/A | $2.66 | N/A |
| Beta (Stock Volatility) | N/A | 1.81 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Core Scientific vs Shift4 Payments Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Core Scientific | -2.43% | -1.02% | 2.33% | 27.24% | 25.83% | -5.34% |
| Shift4 Payments | -1.93% | -0.40% | -16.16% | 1.61% | -6.57% | -18.08% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Core Scientific | 26.88% | 711.90% | 711.90% | 711.90% | 711.90% | 711.90% |
| Shift4 Payments | 9.39% | 93.31% | 72.87% | 164.61% | 164.61% | 164.61% |
Performance & Financial Health Analysis: Core Scientific vs Shift4 Payments
| Metric | CORZZ | FOUR |
|---|---|---|
| Market Information | ||
| Market Cap | $4.20B | $7.97B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 49,074 | 3,444,978 |
| 90 Day Avg. Volume | 55,627 | 1,933,193 |
| Last Close | $13.64 | $88.75 |
| 52 Week Range | $6.32 - $18.56 | $68.09 - $127.50 |
| % from 52W High | -26.51% | -30.39% |
| All-Time High | $18.56 (Nov 25, 2024) | $127.50 (Feb 17, 2025) |
| % from All-Time High | -26.51% | -30.39% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.44% | 0.17% |
| Quarterly Earnings Growth | -0.44% | -0.13% |
| Financial Health | ||
| Profit Margin (TTM) | 0.24% | 0.06% |
| Operating Margin (TTM) | -0.28% | 0.09% |
| Return on Equity (TTM) | 1.60% | 0.18% |
| Debt to Equity (MRQ) | -1.09 | 186.68 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-3.51 | $9.14 |
| Cash per Share (MRQ) | $1.90 | $44.14 |
| Operating Cash Flow (TTM) | $12.92M | $512.00M |
| Levered Free Cash Flow (TTM) | $-125,378,624 | $417.24M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Core Scientific vs Shift4 Payments
| Metric | CORZZ | FOUR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 33.90 |
| Forward P/E | N/A | 18.75 |
| PEG Ratio | N/A | -0.83 |
| Price to Sales (TTM) | 8.23 | 2.21 |
| Price to Book (MRQ) | N/A | 9.87 |
| Market Capitalization | ||
| Market Capitalization | $4.20B | $7.97B |
| Enterprise Value | $4.57B | $8.37B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.95 | 2.32 |
| Enterprise to EBITDA | 42.21 | 13.76 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.81 |
| Book Value per Share (MRQ) | $-3.51 | $9.14 |
Financial Statements Comparison: Core Scientific vs Shift4 Payments
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CORZZ | FOUR |
|---|---|---|
| Revenue/Sales | $79.53M | $848.30M |
| Cost of Goods Sold | $71.31M | $591.30M |
| Gross Profit | $8.21M | $257.00M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $-42.59M | $21.70M |
| EBITDA | $-641.64M | $121.10M |
| Pre-Tax Income | $580.90M | $11.40M |
| Income Tax | $205,000 | $-8.10M |
| Net Income (Profit) | $580.69M | $19.50M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CORZZ | FOUR |
|---|---|---|
| Cash & Equivalents | $697.94M | $1.17B |
| Total Current Assets | $833.18M | $1.84B |
| Total Current Liabilities | $195.51M | $1.36B |
| Long-Term Debt | $1.17B | $2.18B |
| Total Shareholders Equity | $-181.51M | $1.02B |
| Retained Earnings | $-3.15B | $-259.60M |
| Property, Plant & Equipment | $610.44M | $334.80M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CORZZ | FOUR |
|---|---|---|
| Operating Cash Flow | $590.74M | $120.40M |
| Capital Expenditures | $-88.42M | $-31.80M |
| Free Cash Flow | $-129.06M | $44.80M |
| Debt Repayment | $-4.46M | N/A |
| Common Stock Repurchase | N/A | $-62.90M |
Short Interest & Institutional Ownership Analysis
| Metric | CORZZ | FOUR |
|---|---|---|
| Shares Short | N/A | 11.13M |
| Short Ratio | N/A | 9.68 |
| Short % of Float | N/A | 0.17% |
| Average Daily Volume (10 Day) | 49,074 | 3,444,978 |
| Average Daily Volume (90 Day) | 55,627 | 1,933,193 |
| Shares Outstanding | 292.61M | 69.26M |
| Float Shares | 295.63M | 54.20M |
| % Held by Insiders | N/A | 0.02% |
| % Held by Institutions | N/A | 1.34% |
Dividend Analysis & Yield Comparison: Core Scientific vs Shift4 Payments
| Metric | CORZZ | FOUR |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |